Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 2 Oct, 01:30 am
uniQure N.V. (NASDAQ: QURE) fell sharply after a mixed four-year update for its Huntington’s disease gene therapy. Fair Isaac Corporation (NYSE: FICO) dropped as investors reacted to rising competition from VantageScore in mortgage credit scoring. ClearPoint Neuro, Inc. (NA
AAR Corp. (NYSE:AIR) demonstrated strong Q1 financial performance , with total sales of $918 million and an expanded adjusted EBITDA margin of 12.7% . The company is making a significant strategic acquisition of a 65% interest in MRO Holdings, projected to add over $1 billion in
Fair Isaac Corp (NYSE:FICO) faces heightened competition in the U.S. mortgage market from VantageScore following a new FHFA policy. The policy change allows lenders to use the less expensive VantageScore, impacting FICO's long-held pricing advantage. FICO's stock experienced a si
Micron Technology is poised for record revenue, with estimates reaching up to $51.33 billion , driven by strong demand for high-bandwidth memory in the burgeoning AI market . Analysts project a significant increase in earnings per share (EPS) to approximately $31.72 , a substanti
EPS Beat: Sangoma Technologies Corporation (NASDAQ:SANG) significantly surpassed analyst earnings per share (EPS) estimates, reporting a smaller loss than anticipated. Revenue Miss: Despite the positive EPS surprise, Sangoma's reported revenue for the quarter fell slightly short
Analyst Joseph Pantginis of H.C. Wainwright raised his price target for Iovance Biotherapeutics to $20.00 , reflecting significant confidence in the biotechnology stock. The company increased its full-year 2026 total revenue guidance to a range of $410 million to $420 million , i
uniQure (NASDAQ:QURE) experienced a significant stock drop following a four-year update on its AMT-130 gene therapy for Huntington's disease. The AMT-130 therapy's effectiveness in slowing disease progression decreased from 80% at three years to 44% at four years, failing to achi
EPS Beat: Precision Optics Corporation (NASDAQ:POCI) exceeded analyst expectations with an EPS of -$0.01 , beating the estimated -$0.06 . Record Revenue: The company achieved record quarterly revenue of $8.8 million , a 42% increase year-over-year, surpassing analyst estimates. I
Analyst firm Craig-Hallum adjusted its price target for Boot Barn Holdings (NYSE: BOOT) to $224 , indicating a potential 84.91% increase from the stock's price at the time. GuruFocus highlights Boot Barn Holdings (NYSE: BOOT) with a strong GF Score of 91 and assesses it as underv
Sangoma Technologies Corporation (NASDAQ: SANG) is set to be acquired by BRC Group Holdings, Inc. for an enterprise value of approximately $204.00 million . Following the acquisition announcement, Sangoma Technologies Corporation's stock price surged by 35.94% , reaching $4.88 pe
Inventiva (NASDAQ: IVA) , a clinical-stage biopharmaceutical company, remains focused on lanifibranor and its Phase 3 NATiV3 trial in MASH. The company expects topline results from NATiV3 in the fourth quarter of 2026, following completion of the last patient’s final 72-wee
Jabil is scheduled to release its quarterly earnings on September 30, 2026, with analysts projecting earnings per share of $4.07 and revenue of $9.71 billion . The company is seeing strong growth in AI infrastructure , with AI-related revenue for 2026 projected at $13.6 billion ,
Leading streaming company Netflix (NASDAQ:NFLX) gained after Deutsche Bank upgraded the stock from Hold to Buy . Analyst views remain mixed, as Wells Fargo downgraded Netflix to Underweight and HSBC downgraded it to Hold . Despite recent weakness, Netflix still holds a strong pos
Recent insider selling by multiple executives, including the CEO, suggests a notable trend in Cytokinetics stock activity. CEO Robert I. Blum executed significant share sales, including a large block under a pre-arranged Rule 10b5-1 trading plan, totaling millions of dollars. Des
Carnival Corporation (NYSE:CCL) exceeded analyst expectations with strong quarterly earnings, posting an earnings per share of $1.43 and a net income of $1.92 billion . The global cruise operator achieved record revenue of $8.44 billion , driven by accelerating consumer demand fo
FactSet (NYSE:FDS) leverages deeply integrated products to maintain a strong competitive advantage and resilience against disruption from artificial intelligence (AI). Analysts anticipate robust Q3 financial performance, with an earnings per share (EPS) of $4.35 and a consensus r
An analyst price target of $71.00 suggests a significant 50.65% upside for Jefferies Financial Group (NYSE:JEF) . Jefferies Financial Group reported strong Q3 earnings per share (EPS) of $1.09 , surpassing analyst estimates. The company's Q3 revenue grew to $2.22 billion , driven
Analyst firm Evercore ISI maintains an " Outperform " rating for Spotify, raising its price target to $700.00 , signaling a positive long-term outlook despite recent stock declines. Spotify's stock has seen recent declines, closing at $497.51 and falling 6.85% over the past month
Headlines provided by Investing.com